Drug intelligence / Profile preview

MB007

Development stage: Unknown
Lead developer: Beijing Maybio Pharmaceutical Biotechnology Development
Modality: Recombinant Proteins and Enzymes
Administration: Subcutaneous, Intradermal

Overview

MB007 is an innovative, recombinant, cell-derived extracellular matrix (ECM) collagen product developed by Maybio (Meibo Biotech). It is produced via in vitro expression in engineered cells derived from chemically induced pluripotent stem cell (CiPSC) lines, followed by extraction and purification. The resulting ECM collagen features a full-length sequence identical to human collagen, retaining complete tertiary and quaternary structures to provide natural mechanical support and stimulate tissue regeneration with low immunogenicity. MB007 is formulated as an injectable gel and is currently in Phase III clinical development in China for the treatment of microgenia (chin retrusion / mandibular retrusion). In September 2026, Huadong Medicine's wholly-owned subsidiary, Sinclair Aesthetics (Xinkeli Aesthetics), secured exclusive strategic commercialization rights for MB007 in the Chinese market.

Other names: ECM collagen MB007extracellular matrix collagen MB007

Beyond the preview

Go deeper on MB007.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MB007.